ADGRG2
Adhesion G-protein coupled receptor G2
Also known as: AGRG2_HUMAN, EDDM6, GPR64, HE6, TM7LN2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZP9
- Gene
- ADGRG2
- Ensembl
- ENSG00000173698
- Chromosome
- X
- Canonical length
- 1017 aa
- Protein class
- Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the G protein-coupled receptor family described as an epididymis-specific transmembrane protein. The encoded protein may be proteolytically processed as it contains a motif shown to be a protein scission motif in some members of this family (PMID: 11973329). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
1017 residues, UniProt reviewed canonical sequence.
>Q8IZP9|ADGRG2
1 MVFSVRQCGH VGRTEEVLLT FKIFLVIICL HVVLVTSLEE DTDNSSLSPP PAKLSVVSFA
61 PSSNGTPEVE TTSLNDVTLS LLPSNETEKT KITIVKTFNA SGVKPQRNIC NLSSICNDSA
121 FFRGEIMFQY DKESTVPQNQ HITNGTLTGV LSLSELKRSE LNKTLQTLSE TYFIMCATAE
181 AQSTLNCTFT IKLNNTMNAC AVIAALERVK IRPMEHCCCS VRIPCPSSPE ELEKLQCDLQ
241 DPIVCLADHP RGPPFSSSQS IPVVPRATVL SQVPKATSFA EPPDYSPVTH NVPSPIGEIQ
301 PLSPQPSAPI ASSPAIDMPP QSETISSPMP QTHVSGTPPP VKASFSSPTV SAPANVNTTS
361 APPVQTDIVN TSSISDLENQ VLQMEKALSL GSLEPNLAGE MINQVSRLLH SPPDMLAPLA
421 QRLLKVVDDI GLQLNFSNTT ISLTSPSLAL AVIRVNASSF NTTTFVAQDP ANLQVSLETQ
481 APENSIGTIT LPSSLMNNLP AHDMELASRV QFNFFETPAL FQDPSLENLS LISYVISSSV
541 ANLTVRNLTR NVTVTLKHIN PSQDELTVRC VFWDLGRNGG RGGWSDNGCS VKDRRLNETI
601 CTCSHLTSFG VLLDLSRTSV LPAQMMALTF ITYIGCGLSS IFLSVTLVTY IAFEKIRRDY
661 PSKILIQLCA ALLLLNLVFL LDSWIALYKM QGLCISVAVF LHYFLLVSFT WMGLEAFHMY
721 LALVKVFNTY IRKYILKFCI VGWGVPAVVV TIILTISPDN YGLGSYGKFP NGSPDDFCWI
781 NNNAVFYITV VGYFCVIFLL NVSMFIVVLV QLCRIKKKKQ LGAQRKTSIQ DLRSIAGLTF
841 LLGITWGFAF FAWGPVNVTF MYLFAIFNTL QGFFIFIFYC VAKENVRKQW RRYLCCGKLR
901 LAENSDWSKT ATNGLKKQTV NQGVSSSSNS LQSSSNSTNS TTLLVNNDCS VHASGNGNAS
961 TERNGVSFSV QNGDVCLHDF TGKQHMFNEK EDSCNGKGRM ALRRTSKRGS LHFIEQMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADGRG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 1,159 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 1,159 nTPM
- parathyroid gland: 154 nTPM
- fallopian tube: 16 nTPM
- stomach: 8.5 nTPM
- salivary gland: 8 nTPM
- thymus: 6.1 nTPM
Single-cell type
- epididymal principal cells: 2,215 nCPM
- epididymal efferent duct absorptive cells: 888 nCPM
- epididymal efferent duct ciliated cells: 400 nCPM
- adipocytes: 124 nCPM
- epicardial cells: 121 nCPM
- fibro-adipogenic progenitors: 96 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 4.1 nTPM
- cerebral cortex: 3 nTPM
- hippocampal formation: 2.5 nTPM
- hypothalamus: 2.1 nTPM
- pons: 2.1 nTPM
- medulla oblongata: 1.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADGRG2.
Disease | AllUniProt
Conditions ADGRG2 is implicated in, by any mechanism.
- Congenital bilateral aplasia of the vas deferens, X-linked (CBAVDX) MIM:300985
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 346 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital bilateral aplasia of vas deferens from CFTR mutation
- Vas deferens, congenital bilateral aplasia of, X-linked
- Obstructive azoospermia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.93
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
- spermatid development
- spermatogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPS motif
- GPCR, family 2, secretin-like
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- GAIN domain superfamily
- GAIN, subdomain B
- Adhesion G-protein coupled receptor G2/6, GAIN domain
- 7 transmembrane receptor (Secretin family)
- GPCR proteolysis site, GPS, motif
- ADGRG2-like, GAIN domain
- ADGRG2, N-terminal domain
- ADGRG2, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADGRG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADGRG2 as an antibody target. Whether an autoantibody or antibody against ADGRG2 could matter depends on whether native ADGRG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADGRG2 is annotated at the cell surface, where native ADGRG2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADGRG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...